Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

More articles from Articles

  • You have access
    A Computational-Based Approach to Identify Estrogen Receptor α/β Heterodimer Selective Ligands
    Carlos G. Coriano, Fabao Liu, Chelsie K. Sievers, Muxuan Liang, Yidan Wang, Yoongho Lim, Menggang Yu and Wei Xu
    Molecular Pharmacology March 2018, 93 (3) 197-207; DOI: https://doi.org/10.1124/mol.117.108696
  • You have access
    Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion–Induced Kidney and Liver Injury
    You-Jin Choi, Dong Zhou, Anne Caroline S. Barbosa, Yongdong Niu, Xiudong Guan, Meishu Xu, Songrong Ren, Thomas D. Nolin, Youhua Liu and Wen Xie
    Molecular Pharmacology March 2018, 93 (3) 239-250; DOI: https://doi.org/10.1124/mol.117.111146
  • You have access
    Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein–Signaling Family
    Michael P. Hayes, Christopher R. Bodle and David L. Roman
    Molecular Pharmacology January 2018, 93 (1) 25-35; DOI: https://doi.org/10.1124/mol.117.109843
  • You have access
    Human Missense Mutations in Regulator of G Protein Signaling 2 Affect the Protein Function Through Multiple Mechanisms
    Hoa T.N. Phan, Benita Sjögren and Richard R. Neubig
    Molecular Pharmacology October 2017, 92 (4) 451-458; DOI: https://doi.org/10.1124/mol.117.109215
  • You have access
    A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies
    Andrea Martella, Huub Sijben, Arne C. Rufer, Uwe Grether, Juergen Fingerle, Christoph Ullmer, Thomas Hartung, Adriaan P. IJzerman, Mario van der Stelt and Laura H. Heitman
    Molecular Pharmacology October 2017, 92 (4) 389-400; DOI: https://doi.org/10.1124/mol.117.108605
  • You have access
    A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site
    Ramkumar Rajamani, Sophie Wu, Iyoncy Rodrigo, Mian Gao, Simon Low, Lisa Megson, David Wensel, Rick L. Pieschl, Debra J. Post-Munson, John Watson, David R. Langley, Michael K. Ahlijanian, Linda J. Bristow and James Herrington
    Molecular Pharmacology September 2017, 92 (3) 310-317; DOI: https://doi.org/10.1124/mol.117.108712
  • You have access
    Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53
    Xin Yu, Adam Blanden, Ashley T. Tsang, Saif Zaman, Yue Liu, John Gilleran, Anthony F. Bencivenga, S. David Kimball, Stewart N. Loh and Darren R. Carpizo
    Molecular Pharmacology June 2017, 91 (6) 567-575; DOI: https://doi.org/10.1124/mol.116.107409
  • You have access
    Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
    Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
    Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
  • You have access
    Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins
    Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala
    Molecular Pharmacology January 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
  • You have access
    Salmeterol’s Extreme β2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains
    Jillian G. Baker, Richard G. W. Proudman and Stephen J. Hill
    Molecular Pharmacology January 2015, 87 (1) 103-120; DOI: https://doi.org/10.1124/mol.114.095364

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics